ASC41

DRUG2 trials

Sponsors

Ascletis Pharmaceuticals Co., Ltd., Gannex Pharma Co., Ltd.

Conditions

HealthyNAFLD

Phase 1

A Study of the Relative Bioavailability of ASC41 in Healthy Subjects

CompletedNCT04527250

Ascletis Pharmaceuticals Co., Ltd.Healthy

Start: 2020-09-16End: 2020-12-30Updated: 2021-08-20

DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD.

CompletedNCT04845646

Gannex Pharma Co., Ltd.Healthy, NAFLD

Start: 2021-03-16End: 2021-06-10Updated: 2024-09-27